The Best Biotech Stock to Invest $1,000 in Right Now

Viking Therapeutics (NASDAQ: VKTX) is at an exciting point in its history. While it doesn't have any medicines approved for sale at the moment, it has a couple of mid-stage programs that are shaping up to make a big splash in their target markets, assuming they end up getting approved. And that could happen fairly soon.On average, the analysts on Wall Street see the biotech's stock rising by 116% during the next 12 months. That's a sign it's an appealing option for investing a relatively small sum, perhaps as small as $1,000, to capture the large amount of growth that could be on the way. Here's what you need to know.The investment thesis for buying $1,000 of Viking Therapeutics is based on its plans for entering two big markets, one of which is much more important right now than the other.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Zum vollständigen Artikel